A large population in the world is avoiding getting the vaccine due to fear of needles. But now the day is not far when people will not have to deal with the fear of needles to get the safety of the vaccine. Scientists at the University of Cambridge began clinical trials of a needleless, airborne vaccine on Tuesday. This is expected to help in dealing with future forms of COVID. University Professor Jonathan Heaney and the DioSynwax Company developed this DIOswax technology.
Its dose will be injected into the skin through air pressure. If successful, it could be an option in the future for people afraid of getting a needle. It can be manufactured in powdered form to boost global vaccination efforts, especially in low- and middle-income countries. Heaney said, ‘It is important that we continue to develop a new generation of vaccines that will protect against future forms of the virus.’
First step towards universal corona virus vaccine
He said that our vaccine is innovative. This is the first step towards a universal corona virus vaccine we are developing. And will save us not only from the forms of covid-19 but also from future corona virus. This vaccine will be administered to the first volunteer this week. Innovate UK has provided funding under the UK Research and Invention Network for needle-free vaccine trials.
Effective anti covid drug on Omicron
On the other hand, pharmaceutical company Pfizer claimed on Tuesday that its experimental anti-Covid pill has also proved effective against Omicron, a new form of the corona virus. The company said that the full conclusion of research conducted on 2,250 people has confirmed that its anti-Covid pill is effective against the virus. The company said that the drug given to high-risk adults after the initial symptoms of Kovid-19 resulted in a combined reduction of about 89 percent in hospitalizations and deaths.